Intrapleural and Plasma Processing of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) in a Phase 1b Trial of LTI-01 Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要